CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Maduck Sean See Remarks | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2022-12-01 | Maduck Sean See Remarks | Option exercise | +625 | $3.29 | $2K | 57,087 |
| 2022-12-01 | Maduck Sean See Remarks | Sale | −625 | $25.28 | $16K | 56,462 |
| 2022-12-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) | −625 | 31,977 | ||
| 2022-11-23 | Robb Gary Charles Chief Business Officer | Sale | −186 | $26.03 | $5K | 21,143 |
| 2022-11-22 | Robb Gary Charles Chief Business Officer | Sale | −4,814 | $26.03 | $125K | 21,329 |
| 2022-11-18 | Robb Gary Charles Chief Business Officer | Sale | −13,401 | $26.43 | $354K | 26,143 |
| 2022-11-17 | Robb Gary Charles Chief Business Officer | Sale | −10,000 | $26.06 | $261K | 39,544 |
| 2022-11-10 | Maduck Sean See Remarks | Option exercise | +25,000 | $3.29 | $82K | 81,462 |
| 2022-11-10 | Maduck Sean See Remarks | Sale | −25,000 | $25.57 | $639K | 56,462 |
| 2022-11-10 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) | −25,000 | 32,602 | ||
| 2022-10-03 | Maduck Sean See Remarks | Option exercise | +25,000 | $3.29 | $82K | 81,462 |
| 2022-10-03 | Maduck Sean See Remarks | Sale | −25,000 | $25.64 | $641K | 56,462 |
| 2022-10-03 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) | −25,000 | 57,602 | ||
| 2022-09-28 | Hunt Hazel Chief Scientific Officer | Option exercise | +50,000 | $2.08 | $104K | 103,143 |
| 2022-09-28 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −29,997 | $26.04 | $781K | 73,146 |
| 2022-09-28 | Hunt Hazel Chief Scientific Officer | Option exercise · Stock option (right to buy) | −50,000 | 0 | ||
| 2022-09-07 | Robb Gary Charles Chief Business Officer | Sale | −50,000 | $26.06 | $1.3M | 49,544 |
| 2022-09-01 | Maduck Sean See Remarks | Gift | −922 | 40,106 | ||
| 2022-09-01 | Maduck Sean See Remarks | Other acquisition | +922 | 55,516 |
Page 53 of 61 · 1,220 trades